PTO Tougher On Patent Claims Following Claritin Metabolite Ruling – Attorney
Executive Summary
Patenting drug claims has become more difficult due to recent court rulings in Waxman/Hatch cases, attorney Anthony Insogna said during a panel discussion at the J.P. Morgan health care conference in San Francisco Jan. 14